Cost Of Sales Zmiana Data
Acadia Pharmaceuticals USD 17.89M 3.27M 2023-12
ALKERMES USD 61.51M 1.75M 2023-09
BioCryst Pharmaceuticals USD 1.14M 186K 2023-09
Biogen USD 618.3M 41.3M 2023-12
Bristol-Myers Squibb USD 2.71B 217M 2023-12
Esperion Therapeutics USD 13.38M 6.59M 2023-09
Gilead Sciences USD 1.61B 46M 2023-12
Halozyme Therapeutics USD 52.3M 2.52M 2023-12
Intra Cellular Therapies USD 10.7M 1.57M 2023-12
J&J USD 6.8B 418M 2023-12
Marinus Pharmaceuticals USD 455K 69K 2023-09
Nektar Therapeutics USD 12.43M 5.44M 2023-09
Neurocrine Biosciences USD 11.2M 300K 2023-09
RedHill Biopharma USD 806K 806K 2023-06
Supernus Pharmaceuticals USD 19.63M 26K 2023-12
United Therapeutics USD 71M 900K 2023-12
Vanda Pharmaceuticals USD 3.5M 1.27M 2023-06



Intra Cellular Therapies Koszty Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.